E.X. Li
First Affiliated Hospital of Xi'an Jiaotong University · 1 works · 28 citations · h-index 1
Top works
A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment